Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
China Health Group ( (HK:0673) ) just unveiled an announcement.
China Health Group Limited announced measures to address liquidity pressures and a disclaimer of opinion on its financial statements for the year ending March 2026. The company successfully raised approximately HK$80.9 million through subscriptions and a rights issue, and plans to finalize bank borrowing negotiations by early 2026. The board remains vigilant in assessing operational and funding needs, advising shareholders to exercise caution when dealing with company securities.
The most recent analyst rating on (HK:0673) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on China Health Group stock, see the HK:0673 Stock Forecast page.
More about China Health Group
China Health Group Limited operates within the healthcare industry, focusing on providing health-related services and products. The company is incorporated in Bermuda and conducts business in Hong Kong under the name CHG HS Limited.
Average Trading Volume: 841,213
Technical Sentiment Signal: Buy
Current Market Cap: HK$843.7M
Find detailed analytics on 0673 stock on TipRanks’ Stock Analysis page.